Shanghai Pharmaceuticals Holding Co., Ltd
SHPMY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $45 | $39 | $39 | $34 |
| - Cash | $36 | $31 | $27 | $22 |
| + Debt | $48 | $43 | $39 | $32 |
| Enterprise Value | $57 | $51 | $50 | $44 |
| Revenue | $275 | $260 | $232 | $216 |
| % Growth | 5.7% | 12.2% | 7.5% | – |
| Gross Profit | $31 | $31 | $30 | $29 |
| % Margin | 11.1% | 12% | 13.1% | 13.2% |
| EBITDA | $12 | $11 | $12 | $11 |
| % Margin | 4.4% | 4.2% | 5.4% | 5.2% |
| Net Income | $5 | $4 | $6 | $5 |
| % Margin | 1.7% | 1.4% | 2.4% | 2.4% |
| EPS Diluted | 6.15 | 5.1 | 8.05 | 8.95 |
| % Growth | 20.6% | -36.6% | -10.1% | – |
| Operating Cash Flow | $6 | $5 | $5 | $5 |
| Capital Expenditures | -$2 | -$3 | -$3 | -$4 |
| Free Cash Flow | $3 | $2 | $2 | $1 |